Global Recombinant Antibody Sales Market Report 2016

Publisher Name :
Date: 02-Sep-2016
No. of pages: 126
Inquire Before Buying

Notes:

Sales, means the sales volume of Recombinant Antibody

Revenue, means the sales value of Recombinant Antibody

This report studies sales (consumption) of Recombinant Antibody in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia,I50 focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- A.G. Scientific, Inc. (US)

- Abbott Diagnostics (US)

- Agilent Technologies, Inc. (US)

- BD Biosciences (US)

- Beckman Coulter, Inc. (US)

- bioMerieux (France)

- Bio-Rad Laboratories, Inc. (US)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Gallus Immunotech, Inc. (Canada)

- GE Healthcare (UK)

- Lonza Biologics Ltd. (Switzerland)

- Merck KGaA (Germany)

- Meridian Life Science, Inc. (US)

- PerkinElmer, Inc. (US)

- Promega Corporation (US)

- Qiagen N.V. (Netherlands)

- R&D Systems (US)

- SDIX, LLC (US)

- Shimadzu Corporation (Japan)

- Takara Bio, Inc. (Japan)

- Thermo Fisher Scientific Inc. (US)

- Wako Pure Chemical Industries Ltd. (Japan)

- Waters Corp. (US)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Recombinant Antibody in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Antibody in each application, can be divided into

- Medical care

- Experiment

- Application 3

Global Recombinant Antibody Sales Market Report 2016

Table of Contents
Global Recombinant Antibody Sales Market Report 2016
1 Recombinant Antibody Overview
1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Antibody
1.3.1 Medical care
1.3.2 Experiment
1.3.3 Application 3
1.4 Recombinant Antibody Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Recombinant Antibody (2011-2021)
1.5.1 Global Recombinant Antibody Sales and Growth Rate (2011-2021)
1.5.2 Global Recombinant Antibody Revenue and Growth Rate (2011-2021)
2 Global Recombinant Antibody Competition by Manufacturers, Type and Application
2.1 Global Recombinant Antibody Market Competition by Manufacturers
2.1.1 Global Recombinant Antibody Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Recombinant Antibody Revenue and Share by Manufacturers (2011-2016)
2.2 Global Recombinant Antibody (Volume and Value) by Type
2.2.1 Global Recombinant Antibody Sales and Market Share by Type (2011-2016)
2.2.2 Global Recombinant Antibody Revenue and Market Share by Type (2011-2016)
2.3 Global Recombinant Antibody (Volume and Value) by Regions
2.3.1 Global Recombinant Antibody Sales and Market Share by Regions (2011-2016)
2.3.2 Global Recombinant Antibody Revenue and Market Share by Regions (2011-2016)
2.4 Global Recombinant Antibody (Volume) by Application
3 USA Recombinant Antibody (Volume, Value and Sales Price)
3.1 USA Recombinant Antibody Sales and Value (2011-2016)
3.1.1 USA Recombinant Antibody Sales and Growth Rate (2011-2016)
3.1.2 USA Recombinant Antibody Revenue and Growth Rate (2011-2016)
3.1.3 USA Recombinant Antibody Sales Price Trend (2011-2016)
3.2 USA Recombinant Antibody Sales and Market Share by Manufacturers
3.3 USA Recombinant Antibody Sales and Market Share by Type
3.4 USA Recombinant Antibody Sales and Market Share by Application
4 China Recombinant Antibody (Volume, Value and Sales Price)
4.1 China Recombinant Antibody Sales and Value (2011-2016)
4.1.1 China Recombinant Antibody Sales and Growth Rate (2011-2016)
4.1.2 China Recombinant Antibody Revenue and Growth Rate (2011-2016)
4.1.3 China Recombinant Antibody Sales Price Trend (2011-2016)
4.2 China Recombinant Antibody Sales and Market Share by Manufacturers
4.3 China Recombinant Antibody Sales and Market Share by Type
4.4 China Recombinant Antibody Sales and Market Share by Application
5 Europe Recombinant Antibody (Volume, Value and Sales Price)
5.1 Europe Recombinant Antibody Sales and Value (2011-2016)
5.1.1 Europe Recombinant Antibody Sales and Growth Rate (2011-2016)
5.1.2 Europe Recombinant Antibody Revenue and Growth Rate (2011-2016)
5.1.3 Europe Recombinant Antibody Sales Price Trend (2011-2016)
5.2 Europe Recombinant Antibody Sales and Market Share by Manufacturers
5.3 Europe Recombinant Antibody Sales and Market Share by Type
5.4 Europe Recombinant Antibody Sales and Market Share by Application
6 Japan Recombinant Antibody (Volume, Value and Sales Price)
6.1 Japan Recombinant Antibody Sales and Value (2011-2016)
6.1.1 Japan Recombinant Antibody Sales and Growth Rate (2011-2016)
6.1.2 Japan Recombinant Antibody Revenue and Growth Rate (2011-2016)
6.1.3 Japan Recombinant Antibody Sales Price Trend (2011-2016)
6.2 Japan Recombinant Antibody Sales and Market Share by Manufacturers
6.3 Japan Recombinant Antibody Sales and Market Share by Type
6.4 Japan Recombinant Antibody Sales and Market Share by Application
7 India Recombinant Antibody (Volume, Value and Sales Price)
7.1 India Recombinant Antibody Sales and Value (2011-2016)
7.1.1 India Recombinant Antibody Sales and Growth Rate (2011-2016)
7.1.2 India Recombinant Antibody Revenue and Growth Rate (2011-2016)
7.1.3 India Recombinant Antibody Sales Price Trend (2011-2016)
7.2 India Recombinant Antibody Sales and Market Share by Manufacturers
7.3 India Recombinant Antibody Sales and Market Share by Type
7.4 India Recombinant Antibody Sales and Market Share by Application
8 Southeast Asia Recombinant Antibody (Volume, Value and Sales Price)
8.1 Southeast Asia Recombinant Antibody Sales and Value (2011-2016)
8.1.1 Southeast Asia Recombinant Antibody Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Recombinant Antibody Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Recombinant Antibody Sales Price Trend (2011-2016)
8.2 Southeast Asia Recombinant Antibody Sales and Market Share by Manufacturers
8.3 Southeast Asia Recombinant Antibody Sales and Market Share by Type
8.4 Southeast Asia Recombinant Antibody Sales and Market Share by Application
9 Global Recombinant Antibody Manufacturers Analysis
9.1 A.G. Scientific, Inc. (US)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Recombinant Antibody Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 A.G. Scientific, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Abbott Diagnostics (US)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 126 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Abbott Diagnostics (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Agilent Technologies, Inc. (US)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 144 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Agilent Technologies, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 BD Biosciences (US)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Aug Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 BD Biosciences (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Beckman Coulter, Inc. (US)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Beckman Coulter, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 bioMerieux (France)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 bioMerieux (France) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Bio-Rad Laboratories, Inc. (US)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 F. Hoffmann-La Roche Ltd. (Switzerland)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Gallus Immunotech, Inc. (Canada)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Gallus Immunotech, Inc. (Canada) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 GE Healthcare (UK)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 GE Healthcare (UK) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Lonza Biologics Ltd. (Switzerland)
9.12 Merck KGaA (Germany)
9.13 Meridian Life Science, Inc. (US)
9.14 PerkinElmer, Inc. (US)
9.15 Promega Corporation (US)
9.16 Qiagen N.V. (Netherlands)
9.17 R&D Systems (US)
9.18 SDIX, LLC (US)
9.19 Shimadzu Corporation (Japan)
9.20 Takara Bio, Inc. (Japan)
9.21 Thermo Fisher Scientific Inc. (US)
9.22 Wako Pure Chemical Industries Ltd. (Japan)
9.23 Waters Corp. (US)
10 Recombinant Antibody Maufacturing Cost Analysis
10.1 Recombinant Antibody Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Recombinant Antibody
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Recombinant Antibody Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Recombinant Antibody Market Forecast (2016-2021)
14.1 Global Recombinant Antibody Sales, Revenue Forecast (2016-2021)
14.2 Global Recombinant Antibody Sales Forecast by Regions (2016-2021)
14.3 Global Recombinant Antibody Sales Forecast by Type (2016-2021)
14.4 Global Recombinant Antibody Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Recombinant Antibody
Table Classification of Recombinant Antibody
Figure Global Sales Market Share of Recombinant Antibody by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Recombinant Antibody
Figure Global Sales Market Share of Recombinant Antibody by Application in 2015
Figure Medical care Examples
Figure Experiment Examples
Figure USA Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure China Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure Japan Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure India Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Antibody Revenue and Growth Rate (2011-2021)
Figure Global Recombinant Antibody Sales and Growth Rate (2011-2021)
Figure Global Recombinant Antibody Revenue and Growth Rate (2011-2021)
Table Global Recombinant Antibody Sales of Key Manufacturers (2011-2016)
Table Global Recombinant Antibody Sales Share by Manufacturers (2011-2016)
Figure 2015 Recombinant Antibody Sales Share by Manufacturers
Figure 2016 Recombinant Antibody Sales Share by Manufacturers
Table Global Recombinant Antibody Revenue by Manufacturers (2011-2016)
Table Global Recombinant Antibody Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Recombinant Antibody Revenue Share by Manufacturers
Table 2016 Global Recombinant Antibody Revenue Share by Manufacturers
Table Global Recombinant Antibody Sales and Market Share by Type (2011-2016)
Table Global Recombinant Antibody Sales Share by Type (2011-2016)
Figure Sales Market Share of Recombinant Antibody by Type (2011-2016)
Figure Global Recombinant Antibody Sales Growth Rate by Type (2011-2016)
Table Global Recombinant Antibody Revenue and Market Share by Type (2011-2016)
Table Global Recombinant Antibody Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Antibody by Type (2011-2016)
Figure Global Recombinant Antibody Revenue Growth Rate by Type (2011-2016)
Table Global Recombinant Antibody Sales and Market Share by Regions (2011-2016)
Table Global Recombinant Antibody Sales Share by Regions (2011-2016)
Figure Sales Market Share of Recombinant Antibody by Regions (2011-2016)
Figure Global Recombinant Antibody Sales Growth Rate by Regions (2011-2016)
Table Global Recombinant Antibody Revenue and Market Share by Regions (2011-2016)
Table Global Recombinant Antibody Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Recombinant Antibody by Regions (2011-2016)
Figure Global Recombinant Antibody Revenue Growth Rate by Regions (2011-2016)
Table Global Recombinant Antibody Sales and Market Share by Application (2011-2016)
Table Global Recombinant Antibody Sales Share by Application (2011-2016)
Figure Sales Market Share of Recombinant Antibody by Application (2011-2016)
Figure Global Recombinant Antibody Sales Growth Rate by Application (2011-2016)
Figure USA Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure USA Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure USA Recombinant Antibody Sales Price Trend (2011-2016)
Table USA Recombinant Antibody Sales by Manufacturers (2011-2016)
Table USA Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table USA Recombinant Antibody Sales by Type (2011-2016)
Table USA Recombinant Antibody Market Share by Type (2011-2016)
Table USA Recombinant Antibody Sales by Application (2011-2016)
Table USA Recombinant Antibody Market Share by Application (2011-2016)
Figure China Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure China Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure China Recombinant Antibody Sales Price Trend (2011-2016)
Table China Recombinant Antibody Sales by Manufacturers (2011-2016)
Table China Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table China Recombinant Antibody Sales by Type (2011-2016)
Table China Recombinant Antibody Market Share by Type (2011-2016)
Table China Recombinant Antibody Sales by Application (2011-2016)
Table China Recombinant Antibody Market Share by Application (2011-2016)
Figure Europe Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure Europe Recombinant Antibody Sales Price Trend (2011-2016)
Table Europe Recombinant Antibody Sales by Manufacturers (2011-2016)
Table Europe Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table Europe Recombinant Antibody Sales by Type (2011-2016)
Table Europe Recombinant Antibody Market Share by Type (2011-2016)
Table Europe Recombinant Antibody Sales by Application (2011-2016)
Table Europe Recombinant Antibody Market Share by Application (2011-2016)
Figure Japan Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure Japan Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure Japan Recombinant Antibody Sales Price Trend (2011-2016)
Table Japan Recombinant Antibody Sales by Manufacturers (2011-2016)
Table Japan Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table Japan Recombinant Antibody Sales by Type (2011-2016)
Table Japan Recombinant Antibody Market Share by Type (2011-2016)
Table Japan Recombinant Antibody Sales by Application (2011-2016)
Table Japan Recombinant Antibody Market Share by Application (2011-2016)
Figure India Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure India Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure India Recombinant Antibody Sales Price Trend (2011-2016)
Table India Recombinant Antibody Sales by Manufacturers (2011-2016)
Table India Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table India Recombinant Antibody Sales by Type (2011-2016)
Table India Recombinant Antibody Market Share by Type (2011-2016)
Table India Recombinant Antibody Sales by Application (2011-2016)
Table India Recombinant Antibody Market Share by Application (2011-2016)
Figure Southeast Asia Recombinant Antibody Sales and Growth Rate (2011-2016)
Figure Southeast Asia Recombinant Antibody Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Recombinant Antibody Sales Price Trend (2011-2016)
Table Southeast Asia Recombinant Antibody Sales by Manufacturers (2011-2016)
Table Southeast Asia Recombinant Antibody Market Share by Manufacturers (2011-2016)
Table Southeast Asia Recombinant Antibody Sales by Type (2011-2016)
Table Southeast Asia Recombinant Antibody Market Share by Type (2011-2016)
Table Southeast Asia Recombinant Antibody Sales by Application (2011-2016)
Table Southeast Asia Recombinant Antibody Market Share by Application (2011-2016)
Table A.G. Scientific, Inc. (US) Basic Information List
Table A.G. Scientific, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure A.G. Scientific, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table Abbott Diagnostics (US) Basic Information List
Table Abbott Diagnostics (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Diagnostics (US) Recombinant Antibody Global Market Share (2011-2016)
Table Agilent Technologies, Inc. (US) Basic Information List
Table Agilent Technologies, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Agilent Technologies, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table BD Biosciences (US) Basic Information List
Table BD Biosciences (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BD Biosciences (US) Recombinant Antibody Global Market Share (2011-2016)
Table Beckman Coulter, Inc. (US) Basic Information List
Table Beckman Coulter, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Beckman Coulter, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table bioMerieux (France) Basic Information List
Table bioMerieux (France) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure bioMerieux (France) Recombinant Antibody Global Market Share (2011-2016)
Table Bio-Rad Laboratories, Inc. (US) Basic Information List
Table Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bio-Rad Laboratories, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Antibody Global Market Share (2011-2016)
Table Gallus Immunotech, Inc. (Canada) Basic Information List
Table Gallus Immunotech, Inc. (Canada) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Gallus Immunotech, Inc. (Canada) Recombinant Antibody Global Market Share (2011-2016)
Table GE Healthcare (UK) Basic Information List
Table GE Healthcare (UK) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare (UK) Recombinant Antibody Global Market Share (2011-2016)
Table Lonza Biologics Ltd. (Switzerland) Basic Information List
Table Lonza Biologics Ltd. (Switzerland) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Lonza Biologics Ltd. (Switzerland) Recombinant Antibody Global Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck KGaA (Germany) Recombinant Antibody Global Market Share (2011-2016)
Table Meridian Life Science, Inc. (US) Basic Information List
Table Meridian Life Science, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Meridian Life Science, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure PerkinElmer, Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table Promega Corporation (US) Basic Information List
Table Promega Corporation (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Promega Corporation (US) Recombinant Antibody Global Market Share (2011-2016)
Table Qiagen N.V. (Netherlands) Basic Information List
Table Qiagen N.V. (Netherlands) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Qiagen N.V. (Netherlands) Recombinant Antibody Global Market Share (2011-2016)
Table R&D Systems (US) Basic Information List
Table R&D Systems (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure R&D Systems (US) Recombinant Antibody Global Market Share (2011-2016)
Table SDIX, LLC (US) Basic Information List
Table SDIX, LLC (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure SDIX, LLC (US) Recombinant Antibody Global Market Share (2011-2016)
Table Shimadzu Corporation (Japan) Basic Information List
Table Shimadzu Corporation (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shimadzu Corporation (Japan) Recombinant Antibody Global Market Share (2011-2016)
Table Takara Bio, Inc. (Japan) Basic Information List
Table Takara Bio, Inc. (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takara Bio, Inc. (Japan) Recombinant Antibody Global Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (US) Basic Information List
Table Thermo Fisher Scientific Inc. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific Inc. (US) Recombinant Antibody Global Market Share (2011-2016)
Table Wako Pure Chemical Industries Ltd. (Japan) Basic Information List
Table Wako Pure Chemical Industries Ltd. (Japan) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Wako Pure Chemical Industries Ltd. (Japan) Recombinant Antibody Global Market Share (2011-2016)
Table Waters Corp. (US) Basic Information List
Table Waters Corp. (US) Recombinant Antibody Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Waters Corp. (US) Recombinant Antibody Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2015
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure Global Recombinant Antibody Sales and Growth Rate Forecast (2016-2021)
Figure Global Recombinant Antibody Revenue and Growth Rate Forecast (2016-2021)
Table Global Recombinant Antibody Sales Forecast by Regions (2016-2021)
Table Global Recombinant Antibody Sales Forecast by Type (2016-2021)
Table Global Recombinant Antibody Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Dental Bone Graft Substitutes Market Professional Survey Report 2017
    Published: 27-Apr-2017        Price: US 3500 Onwards        Pages: 111
    This report studies Dental Bone Graft Substitutes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Geistlich - Zimmer - DePuy Synthes - Biomet - S......
  • Asia-Pacific Interferon Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Interferon market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Interferon for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Hyaluronic Acid Solution Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the Asia-Pacific Hyaluronic Acid Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Hyaluronic Acid Solution for these regions, from 2012 to 2022 (forecast), including - China - Japan - Sou......
  • Asia-Pacific Gastrointestinal Surgery Tissue Adhesive Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the Asia-Pacific Gastrointestinal Surgery Tissue Adhesive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Gastrointestinal Surgery Tissue Adhesive for these regions, from 2012 to 2022 (forecast), including - Chi......
  • Asia-Pacific Citrus Bioflavonoids Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Citrus Bioflavonoids market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Citrus Bioflavonoids for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Bioresorbable Implants Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the Asia-Pacific Bioresorbable Implants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Bioresorbable Implants for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kor......
  • Asia-Pacific Anti-Infectives Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Anti-Infectives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-Infectives for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Albendazole Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the Asia-Pacific Albendazole market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Albendazole for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • EMEA (Europe, Middle East and Africa) Vascular Endothelial Growth Factor Inhibitor Market Report 2017
    Published: 27-Apr-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Vascular Endothelial Growth Factor Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Vascular Endothelial Growth Factor Inhibitor for these regions, from 2012 to 2022 (forecast) - Europe:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs